![]() |
Technical Data |
|
V2110-04 |
Vascular Endothelial Growth Factor, Recombinant, Human (VEGF) |
10ug |
| Growth Factors, Cytokines | Storage: -70°CShipping: Dry Ice |
|
Recombinant Human Vascular Endothelial Cell Growth Factor (VEGF) is a dimer (composed of two 22kD chains, each chain containing 165 amino acid residues). Produced from recombinant human DNA expressed in baculovirus infected Sf21cells. Vascular Endothelial Cell Growth Factor (VEGF) is a secreted homodimeric protein secreted by a variety of vascularized tissues. The reported activities of VEGF include stimulation of endothelial cell growth, angiogenesis, and capillary permeability. Human VEGF is a 38.2kD protein consisting of two 165 amino acid polypeptide chains. Cell Proliferation Assay: VEGF activity was determined as the ability to stimulate proliferation of human umbilical vein endothelial cells (HUVE cells) during a ve day growth assay. In the assay described below, this lot at 2ng/ml stimulated cell proliferation 1.4fold over the untreated control. Results may vary depending on the cell line used. VEGF will also stimulate endothelial cells from other species. Dilution: VEGF is acid stable. Dilute in either 0.1% TFA or 4mM HCl, containing 25ug BSA per ug VEGF to maintain stability. Reducing agents (such as dithiothreitol or 2-mercaptoethanol) inhibit VEGF activity. Storage and Stability: For long-term storage, aliquot to avoid repeated freezing and thawing and freeze at -70°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquots are stable for at least 12 months. |
Source: Recombinant, Human expressed in Sf21 cells Purity: Ion exchange chromatography followed by 0.2um lter sterilization. Concentration: ~0.2mg/ml Form: 10ug of VEGF in 50ul of 25mM HEPES and 150mM NaCl, pH 7.0. Carrier free. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
1. Myoken, Y., et al., Proc. Natl. Acad. Sci. USA 88: 5819–5823, 1991.
|
||